NRX PHARMACEUTICALS, INC. — Balance Sheet Charts
33 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+254.9% +$9M
$13M
Current Assets↑+169.3% +$6M
$9M
Cash & Equivalents↑+440.3% +$6M
$8M
Receivables
$161K
Net PPE↑+530.0% +$53K
$63K
Goodwill
$2M
Intangibles
$925K
Total Liabilities↑+7.5% +$2M
$29M
Current Liabilities↑+30.7% +$7M
$29M
Account Payables↑+3.4% +$140K
$4M
Long-Term Debt↓-13.0% -$1M
$9M
Stockholders Equity↑+31.4% +$7M
$-16M
Retained Earnings↓-10.3% -$29M
$-307M
Operating Lease ROU Asset
$350K
Operating Lease Liability
$631K
Gross PP&E↑+220.7% +$64K
$93K
Accumulated Depreciation↑+57.9% +$11K
$30K
Total Debt Carrying Amount↑+0.0% +$0
$11M
Contract Liability↓-92.8% -$719K
$56K
Contract Liability (Current)↓-92.8% -$719K
$56K